Order Article Reprints

Gomes-da-Silva NC, Xavier-de-Britto I, Soares MAG, Yoshihara NMA, Ilem Özdemir D, Ricci-Junior E, Fechine PBA, Alencar LMR, Henriques MdGMdO, Barja-Fidalgo TC, et al. Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer’s Disease (Proof of Concept). Pharmaceutics. 2025; 17(5):649. https://doi.org/10.3390/pharmaceutics17050649

Gomes-da-Silva, Natália Cristina, Isabelle Xavier-de-Britto, Marilia Amável Gomes Soares, Natalia Mayumi Andrade Yoshihara, Derya Ilem Özdemir, Eduardo Ricci-Junior, Pierre Basílio Almeida Fechine, Luciana Magalhães Rebelo Alencar, Maria das Graças Muller de Oliveira Henriques, Thereza Christina Barja-Fidalgo, and et al. 2025. "Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer’s Disease (Proof of Concept)" Pharmaceutics 17, no. 5: 649. https://doi.org/10.3390/pharmaceutics17050649

Gomes-da-Silva, N. C., Xavier-de-Britto, I., Soares, M. A. G., Yoshihara, N. M. A., Ilem Özdemir, D., Ricci-Junior, E., Fechine, P. B. A., Alencar, L. M. R., Henriques, M. d. G. M. d. O., Barja-Fidalgo, T. C., Follmer, C., & Santos-Oliveira, R. (2025). Nanostructured Lipoxin A4: Understanding Its Biological Behavior and Impact on Alzheimer’s Disease (Proof of Concept). Pharmaceutics, 17(5), 649. https://doi.org/10.3390/pharmaceutics17050649